648 related articles for article (PubMed ID: 31806706)
1. Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity.
Kinyamu HK; Bennett BD; Bushel PR; Archer TK
J Biol Chem; 2020 Jan; 295(5):1271-1287. PubMed ID: 31806706
[TBL] [Abstract][Full Text] [Related]
2. Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription.
Kinyamu HK; Archer TK
Mol Cell Biol; 2007 Jul; 27(13):4891-904. PubMed ID: 17438138
[TBL] [Abstract][Full Text] [Related]
3. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.
Kinyamu HK; Collins JB; Grissom SF; Hebbar PB; Archer TK
Mol Carcinog; 2008 Nov; 47(11):845-85. PubMed ID: 18381591
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide RNA polymerase II profiles and RNA accumulation reveal kinetics of transcription and associated epigenetic changes during diurnal cycles.
Le Martelot G; Canella D; Symul L; Migliavacca E; Gilardi F; Liechti R; Martin O; Harshman K; Delorenzi M; Desvergne B; Herr W; Deplancke B; Schibler U; Rougemont J; Guex N; Hernandez N; Naef F;
PLoS Biol; 2012; 10(11):e1001442. PubMed ID: 23209382
[TBL] [Abstract][Full Text] [Related]
5. Differential patterns of intronic and exonic DNA regions with respect to RNA polymerase II occupancy, nucleosome density and H3K36me3 marking in fission yeast.
Wilhelm BT; Marguerat S; Aligianni S; Codlin S; Watt S; Bähler J
Genome Biol; 2011 Aug; 12(8):R82. PubMed ID: 21859475
[TBL] [Abstract][Full Text] [Related]
6. CBP Regulates Recruitment and Release of Promoter-Proximal RNA Polymerase II.
Boija A; Mahat DB; Zare A; Holmqvist PH; Philip P; Meyers DJ; Cole PA; Lis JT; Stenberg P; Mannervik M
Mol Cell; 2017 Nov; 68(3):491-503.e5. PubMed ID: 29056321
[TBL] [Abstract][Full Text] [Related]
7. Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-α gene in acute kidney injury.
Bomsztyk K; Flanagin S; Mar D; Mikula M; Johnson A; Zager R; Denisenko O
PLoS One; 2013; 8(7):e70322. PubMed ID: 23936185
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II.
Dennis AP; Lonard DM; Nawaz Z; O'Malley BW
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):337-46. PubMed ID: 15857753
[TBL] [Abstract][Full Text] [Related]
9. RNA Pol II Dynamics Modulate Co-transcriptional Chromatin Modification, CTD Phosphorylation, and Transcriptional Direction.
Fong N; Saldi T; Sheridan RM; Cortazar MA; Bentley DL
Mol Cell; 2017 May; 66(4):546-557.e3. PubMed ID: 28506463
[TBL] [Abstract][Full Text] [Related]
10. Gene induction and repression during terminal erythropoiesis are mediated by distinct epigenetic changes.
Wong P; Hattangadi SM; Cheng AW; Frampton GM; Young RA; Lodish HF
Blood; 2011 Oct; 118(16):e128-38. PubMed ID: 21860024
[TBL] [Abstract][Full Text] [Related]
11. MAP Kinase-Dependent RUNX2 Phosphorylation Is Necessary for Epigenetic Modification of Chromatin During Osteoblast Differentiation.
Li Y; Ge C; Franceschi RT
J Cell Physiol; 2017 Sep; 232(9):2427-2435. PubMed ID: 27514023
[TBL] [Abstract][Full Text] [Related]
12. Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription.
Francis J; Chakrabarti SK; Garmey JC; Mirmira RG
J Biol Chem; 2005 Oct; 280(43):36244-53. PubMed ID: 16141209
[TBL] [Abstract][Full Text] [Related]
13. Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation.
Tummala P; Mali RS; Guzman E; Zhang X; Mitton KP
Mol Vis; 2010 Feb; 16():252-71. PubMed ID: 20161818
[TBL] [Abstract][Full Text] [Related]
14. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression.
Wen H; Li Y; Xi Y; Jiang S; Stratton S; Peng D; Tanaka K; Ren Y; Xia Z; Wu J; Li B; Barton MC; Li W; Li H; Shi X
Nature; 2014 Apr; 508(7495):263-8. PubMed ID: 24590075
[TBL] [Abstract][Full Text] [Related]
15. Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription.
Chia DJ; Young JJ; Mertens AR; Rotwein P
Mol Endocrinol; 2010 Apr; 24(4):779-89. PubMed ID: 20160126
[TBL] [Abstract][Full Text] [Related]
16. The RNA polymerase II transcriptional machinery and its epigenetic context.
Barrero MJ; Malik S
Subcell Biochem; 2013; 61():237-59. PubMed ID: 23150254
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor bortezomib induces an inhibitory chromatin environment at a distal enhancer of the estrogen receptor-α gene.
Powers GL; Rajbhandari P; Solodin NM; Bickford B; Alarid ET
PLoS One; 2013; 8(12):e81110. PubMed ID: 24339902
[TBL] [Abstract][Full Text] [Related]
18. Release of promoter-proximal paused Pol II in response to histone deacetylase inhibition.
Vaid R; Wen J; Mannervik M
Nucleic Acids Res; 2020 May; 48(9):4877-4890. PubMed ID: 32297950
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of histone survival during transcription by RNA polymerase II.
Kulaeva OI; Studitsky VM
Transcription; 2010; 1(2):85-8. PubMed ID: 21326897
[TBL] [Abstract][Full Text] [Related]
20. Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation.
Gates LA; Shi J; Rohira AD; Feng Q; Zhu B; Bedford MT; Sagum CA; Jung SY; Qin J; Tsai MJ; Tsai SY; Li W; Foulds CE; O'Malley BW
J Biol Chem; 2017 Sep; 292(35):14456-14472. PubMed ID: 28717009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
